IMPROVED SURVIVAL AND PROGNOSTIC ABILITY IN LUNG CANCER PATIENTS WITH BRAIN METASTASES: AN UPDATE OF THE GRADED PROGNOSTIC ASSESSMENT FOR LUNG CANCER USING MOLECULAR MARKERS (LUNG-molGPA)

被引：0

作者：

Sperduto, Paul ^{[1
,2
]}

Yang, T. Jonathan ^{[3
]}

Beal, Kathryn ^{[3
]}

Pan, Hubert ^{[4
]}

Brown, Paul ^{[4
]}

Bangdiwala, Ananta ^{[5
]}

Shanley, Ryan ^{[5
]}

Yeh, Norman ^{[6
]}

Gaspar, Laurie E. ^{[6
]}

Braunstein, Steve ^{[7
]}

Sneed, Penny ^{[7
]}

Boyle, John M. ^{[8
]}

Kirkpatrick, John ^{[8
]}

Mak, Kimberley ^{[9
]}

Shih, Helen ^{[9
]}

Engelman, Alex ^{[10
]}

Roberge, David ^{[11
]}

Arvold, Nils ^{[12
]}

Alexander, Brian ^{[12
]}

Awad, Mark ^{[12
]}

Contessa, Joseph ^{[13
]}

Chiang, Veronica ^{[14
]}

Hardie, John ^{[15
]}

Ma, Daniel ^{[15
]}

Lou, Emil ^{[16
]}

Sperduto, William ^{[17
]}

Mehta, Minesh ^{[18
]}

机构：

[1] Univ Minnesota, Gamma Knife Ctr, Minneapolis, MN USA

[2] Univ Minnesota, Minneapolis Radiat Oncol, Minneapolis, MN USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[5] Univ Minnesota, Med Ctr, Dept Biostat, Minneapolis, MN 55455 USA

[6] Univ Colorado, Denver, CO 80202 USA

[7] Univ Calif San Francisco, San Francisco, CA 94143 USA

[8] Duke Univ, Med Ctr, Durham, NC USA

[9] Massachusetts Gen Hosp, Boston, MA 02114 USA

[10] Univ Maryland, Baltimore, MD 21201 USA

[11] Univ Montreal, CHUM, Montreal, PQ, Canada

[12] Dana Farber Canc Inst, Boston, MA 02115 USA

[13] Yale Med Ctr, New Haven, CT USA

[14] Yale Univ, New Haven, CT USA

[15] Mayo Clin, Rochester, MN USA

[16] Univ Minnesota, Med Ctr, Minneapolis, MN 55455 USA

[17] Duke Univ, Durham, NC USA

[18] Miami Canc Inst, Miami, FL USA

来源：

NEURO-ONCOLOGY | 2016年 / 18卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

BMET-06

引用

页码：27 / 27

页数：1

共 50 条

[1] Estimating Survival in Patients With Lung Cancer and Brain Metastases An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Sperduto, Paul W.
Yang, T. Jonathan
Beal, Kathryn
Pan, Hubert
Brown, Paul D.
Bangdiwala, Ananta
Shanley, Ryan
Yeh, Norman
Gaspar, Laurie E.
Braunstein, Steve
Sneed, Penny
Boyle, John
Kirkpatrick, John P.
Mak, Kimberley S.
Shih, Helen A.
Engelman, Alex
Roberge, David
Arvold, Nils D.
Alexander, Brian
Awad, Mark M.
Contessa, Joseph
Chiang, Veronica
Hardie, John
Ma, Daniel
Lou, Emil
Sperduto, William
Mehta, Minesh P.
JAMA ONCOLOGY, 2017, 3 (06) : 827 - 831
[2] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Carsten Nieder
Mandy Hintz
Oliver Oehlke
Angelika Bilger
Anca L. Grosu
Radiation Oncology, 12
[3] Validation of the graded prognostic assessment for lung cancer with brain metastases using molecular markers (lung-molGPA)
Nieder, Carsten
Hintz, Mandy
Oehlke, Oliver
Bilger, Angelika
Grosu, Anca L.
RADIATION ONCOLOGY, 2017, 12
[4] Estimating Survival in Patients with Non-small Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Jing, W.
Li, J.
Zhai, X.
Jia, W.
Hou, Y.
Zhu, H.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E166 - E166
[5] Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Li, Ji
Jing, Wang
Zhai, Xiaoyang
Jia, Wenxiao
Zhu, Hui
Yu, Jinming
ONCOTARGETS AND THERAPY, 2021, 14 : 1623 - 1631
[6] External Validation of the Graded Prognostic Assessment for Patients with Non-Small Cell Lung Cancer and Brain Metastases Using Molecular Markers (Lung-molGPA)
Hong, S. W.
Jeon, W.
Kim, J. S., Jr.
Song, C.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E24 - E25
[7] Selecting Optimal Timing of Cranial Radiotherapy Based on the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA) in Patients with NonSmall Cell Lung Cancer and Brain Metastases
Zhai, X.
Li, J.
Jing, W.
Jia, W.
Zhu, H.
Yu, J.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E66 - E66
[8] Applicability of the adjusted graded prognostic assessment for lung cancer with brain metastases using molecular markers (Lung-molGPA) in a Chinese cohort: A retrospective study of multiple institutions
Zhang, Tingyou
Zhang, Yu
Zhou, Lin
Deng, Shanshan
Huang, Meijuan
Liu, Yuncong
Liu, Yongmei
Gong, Youlin
Zhu, Jiang
Xue, Jianxin
Bai, Yuju
Ma, Hu
Zhang, Yan
Yu, Min
Li, Yanying
Wang, Yongsheng
Zou, Bingwen
Zhou, Xiaojuan
Xiu, Weigang
Na, Feifei
Xu, Yong
Peng, Feng
Wang, Jin
Lu, You
CANCER MEDICINE, 2020, 9 (23): : 8772 - 8781
[9] Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases
Li, Hongwei
Lian, Jianhong
Han, Songyan
Wang, Weili
Jia, Haixia
Cao, Jianzhong
Zhang, Xiaqin
Song, Xin
Jia, Sufang
Ren, Jiwei
Yang, Weihua
Xi, Yanfeng
Lan, Shengmin
ONCOTARGET, 2017, 8 (41) : 70727 - 70735
[10] Selecting optimal timing of cranial radiotherapy-based on the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA) in patients with non-small cell lung cancer and brain metastases.
Zhai, Xiaoyang
Li, Ji
Jing, Wang
Jia, Wenxiao
Zhu, Hui
Yu, Jinming
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)

← 1 2 3 4 5 →